'Akzo
Nobel India consolidated net sales increased 4.65% to Rs 1032.7 crore in Q3FY24
compared to Q3FY23. Operating profit margin has jumped from 14.48% to 16.11%,
leading to 16.45% rise in operating profit to Rs 166.40 crore. Raw material cost as a % of total sales (net
of stock adjustments) decreased from 52.85% to 47.47%. Purchase of finished goods cost rose from
4.83% to 5.64%. Employee cost increased
from 8.41% to 8.47%. Other expenses
rose from 18.20% to 21.28%.
Other
income fell 32.26% to Rs 8.4 crore.
PBIDT rose 12.56% to Rs 174.8 crore.
Provision for interest rose 23.08% to Rs 3.2 crore.
PBDT
rose 12.38% to Rs 171.6 crore.
Provision
for depreciation fell 4.74% to Rs 20.1 crore.&nb...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|